The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1β
Open accessAbstract
Metastasis is the primary cause of cancer death. The inflammatory tumor microenvironment contributes to metastasis, for instance, by recruiting blood and lymph vessels. Among tumor-infiltrating immune cells, tumor-associated macrophages (TAMs) take a center stage in promoting both tumor angiogenesis and metastatic spread. We found that genetic deletion of the S1P receptor 1 (S1pr1) alone in CD11bhi CD206+ TAMs infiltrating mouse breast tumors prevents pulmonary metastasis and tumor lymphangiogenesis. Reduced lymphangiogenesis was also observed in the nonrelated methylcholanthrene-induced fibrosarcoma model. Transcriptome analysis of isolated TAMs from both entities revealed reduced expression of the inflammasome component Nlrp3 in S1PR1-deficient TAMs. Macrophage-dependent lymphangiogenesis in vitro was triggered upon inflammasome activation and required both S1PR1 signaling and IL-1β production. Finally, NLRP3 expression in tumor-infiltrating macrophages correlated with survival, lymph node invasion, and metastasis of mammary carcinoma patients. Conceptually, our study indicates an unappreciated role of the NLRP3 inflammasome in promoting metastasis via the lymphatics downstream of S1PR1 signaling in macrophages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Tumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
A global double-fluorescent Cre reporter mouse
Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L., & Luo, L. (2007) · genesis · doi:10.1002/dvg.20335 · Cited by 3,491
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
Elliott, M. R., Chekeni, F. B., Trampont, P. C., Lazarowski, E. R., Kadl, A., Walk, S. F., Park, D., Woodson, R. I., Ostankovich, M., Sharma, P., et al. (2009) · Nature · doi:10.1038/nature08296 · Cited by 1,654
The role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642
Macrophages and Therapeutic Resistance in Cancer
Ruffell, B., & Coussens, L. M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.015 · Cited by 1,474
The cellular and molecular origin of tumor-associated macrophages
Franklin, R. A., Liao, W., Sarkar, A., Kim, M. V., Bivona, M. R., Liu, K., Pamer, E. G., & Li, M. O. (2014) · Science · doi:10.1126/science.1252510 · Cited by 1,393
Immune cell promotion of metastasis
Kitamura, T., Qian, B.-Z., & Pollard, J. W. (2015) · Nature Reviews Immunology · doi:10.1038/nri3789 · Cited by 1,158
Lin, E. Y., Jones, J. G., Li, P., Zhu, L., Whitney, K. D., Muller, W. J., & Pollard, J. W. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63568-7 · Cited by 1,107
The lymphatic vasculature in disease
Alitalo, K. (2011) · Nature Medicine · doi:10.1038/nm.2545 · Cited by 962
Kelm, J. M., Timmins, N. E., Brown, C. J., Fussenegger, M., & Nielsen, L. K. (2003) · Biotechnology and Bioengineering · doi:10.1002/bit.10655 · Cited by 934
Sphingosine 1-phosphate and cancer
Pyne, N. J., & Pyne, S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2875 · Cited by 852
Allen, I. C., TeKippe, E. M., Woodford, R.-M. T., Uronis, J. M., Holl, E. K., Rogers, A. B., Herfarth, H. H., Jobin, C., & Ting, J. P.-Y. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100050 · Cited by 826
Lymphangiogenesis and lymphatic vessel remodelling in cancer
Stacker, S. A., Williams, S. P., Karnezis, T., Shayan, R., Fox, S. B., & Achen, M. G. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3677 · Cited by 807
Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome
Iyer, S. S., Pulskens, W. P., Sadler, J. J., Butter, L. M., Teske, G. J., Ulland, T. K., Eisenbarth, S. C., Florquin, S., Flavell, R. A., Leemans, J. C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908698106 · Cited by 691
Qian, B., Deng, Y., Im, J. H., Muschel, R. J., Zou, Y., Li, J., Lang, R. A., & Pollard, J. W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006562 · Cited by 664
Gene expression profiling of the tumor microenvironment during breast cancer progression
Ma, X.-J., Dahiya, S., Richardson, E., Erlander, M., & Sgroi, D. C. (2009) · Breast Cancer Research · doi:10.1186/bcr2222 · Cited by 629
Inflammasomes in carcinogenesis and anticancer immune responses
Zitvogel, L., Kepp, O., Galluzzi, L., & Kroemer, G. (2012) · Nature Immunology · doi:10.1038/ni.2224 · Cited by 593 · cited 1×
“Moreover, immunogenic chemotherapy relies on inflammasome activation in dendritic cells and subsequent IL-1β generation to mount protective immunity against tumors (Zitvogel et al., 2012).”
BackgroundMechanisms of lymphatic metastasis
Karaman, S., & Detmar, M. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71606 · Cited by 584
Visentin, B., Vekich, J. A., Sibbald, B. J., Cavalli, A. L., Moreno, K. M., Matteo, R. G., Garland, W. A., Lu, Y., Yu, S., Hall, H. S., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.02.023 · Cited by 463
Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond
Kunkel, G. T., Maceyka, M., Milstien, S., & Spiegel, S. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4099 · Cited by 434
Ristimäki, A., Narko, K., Enholm, B., Joukov, V., & Alitalo, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.14.8413 · Cited by 400
STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors
Lee, H., Deng, J., Kujawski, M., Yang, C., Liu, Y., Herrmann, A., Kortylewski, M., Horne, D., Somlo, G., Forman, S., et al. (2010) · Nature Medicine · doi:10.1038/nm.2250 · Cited by 395
M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis
Kubota, Y., Takubo, K., Shimizu, T., Ohno, H., Kishi, K., Shibuya, M., Saya, H., & Suda, T. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081605 · Cited by 388
Sceneay, J., Chow, M. T., Chen, A., Halse, H. M., Wong, C. S. F., Andrews, D. M., Sloan, E. K., Parker, B. S., Bowtell, D. D., Smyth, M. J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3873 · Cited by 364
Genetics of lymphatic anomalies
Brouillard, P., Boon, L., & Vikkula, M. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71614 · Cited by 355
Fleming, I., Fisslthaler, B., Dixit, M., & Busse, R. (2005) · Journal of Cell Science · doi:10.1242/jcs.02541 · Cited by 327
Self-citationNagahashi, M., Ramachandran, S., Kim, E. Y., Allegood, J. C., Rashid, O. M., Yamada, A., Zhao, R., Milstien, S., Zhou, H., Spiegel, S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2167 · Cited by 315
Inflammasomes in cancer: a double-edged sword
Kolb, R., Liu, G.-H., Janowski, A. M., Sutterwala, F. S., & Zhang, W. (2014) · Protein & Cell · doi:10.1007/s13238-013-0001-4 · Cited by 287
Krelin, Y., Voronov, E., Dotan, S., Elkabets, M., Reich, E., Fogel, M., Huszar, M., Iwakura, Y., Segal, S., Dinarello, C. A., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2956 · Cited by 285
Tumor Promotion via Injury- and Death-Induced Inflammation
Kuraishy, A., Karin, M., & Grivennikov, S. I. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.006 · Cited by 261
S1PR1-STAT3 Signaling Is Crucial for Myeloid Cell Colonization at Future Metastatic Sites
Deng, J., Liu, Y., Lee, H., Herrmann, A., Zhang, W., Zhang, C., Shen, S., Priceman, S. J., Kujawski, M., Pal, S. K., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.03.039 · Cited by 252
Lymphangiogenesis and lymphatic metastasis in breast cancer
Ran, S., Volk, L., Hall, K., & Flister, M. J. (2010) · Pathophysiology · doi:10.1016/j.pathophys.2009.11.003 · Cited by 250
Emerging roles of lymphatic endothelium in regulating adaptive immunity
Card, C. M., Yu, S. S., & Swartz, M. A. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73316 · Cited by 225
The crucial role of macrophages in lymphangiogenesis
Kerjaschki, D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26354 · Cited by 225
Weis, N., Weigert, A., von Knethen, A., & Brüne, B. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-10-1005 · Cited by 167
Self-citationEubank, T. D., Roberts, R. D., Khan, M., Curry, J. M., Nuovo, G. J., Kuppusamy, P., & Marsh, C. B. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1405 · Cited by 166
Degagné, É., Pandurangan, A. K., Bandhuvula, P., Kumar, A., Eltanawy, A., Zhang, M., Yoshinaga, Y., Nefedov, M. D., de Jong, P. J., Fong, L. G., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74188 · Cited by 161
Gordon, E. J., Rao, S., Pollard, J. W., Nutt, S. L., Lang, R. A., & Harvey, N. L. (2010) · Development · doi:10.1242/dev.050021 · Cited by 154
Du, W., Takuwa, N., Yoshioka, K., Okamoto, Y., Gonda, K., Sugihara, K., Fukamizu, A., Asano, M., & Takuwa, Y. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2722 · Cited by 142
Watari, K., Shibata, T., Kawahara, A., Sata, K.-I., Nabeshima, H., Shinoda, A., Abe, H., Azuma, K., Murakami, Y., Izumi, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099568 · Cited by 104
Cleavage of sphingosine kinase 2 by caspase-1 provokes its release from apoptotic cells
Weigert, A., Cremer, S., Schmidt, M. V., von Knethen, A., Angioni, C., Geißlinger, G., & Brüne, B. (2010) · Blood · doi:10.1182/blood-2009-10-243444 · Cited by 103
Self-citationLymphatic Vessels, Inflammation, and Immunity in Skin Cancer
Lund, A. W., Medler, T. R., Leachman, S. A., & Coussens, L. M. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0023 · Cited by 102
Zhu, G., Huang, Q., Huang, Y., Zheng, W., Jin, H., Yang, S., Zhuang, J., Wang, J., & Ye, J. (2016) · Oncotarget · doi:10.18632/oncotarget.12449 · Cited by 91
Min, Y., Ghose, S., Boelte, K. C., Li, J., Yang, L., & Lin, P. (2011) · Oncogene · doi:10.1038/onc.2011.187 · Cited by 84
Macrophages programmed by apoptotic cells promote angiogenesis via prostaglandin E 2
Brecht, K., Weigert, A., Hu, J., Popp, R., Fißlthaler, B., Korff, T., Fleming, I., Geißlinger, G., & Brüne, B. (2011) · The FASEB Journal · doi:10.1096/fj.10-179473 · Cited by 81
Self-citationChikarmane, S. A., Tirumani, S. H., Howard, S. A. H., Jagannathan, J. P., & DiPiro, P. J. (2014) · Clinical Radiology · doi:10.1016/j.crad.2014.08.015 · Cited by 78
Apoptotic cells enhance sphingosine‐1‐phosphate receptor 1 dependent macrophage migration
Weichand, B., Weis, N., Weigert, A., Grossmann, N., Levkau, B., & Brüne, B. (2013) · European Journal of Immunology · doi:10.1002/eji.201343441 · Cited by 68
Self-citationOlesch, C., Sha, W., Angioni, C., Sha, L. K., Açaf, E., Patrignani, P., Jakobsson, P., Radeke, H. H., Grösch, S., Geißlinger, G., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3581 · Cited by 65
Self-citationHIF-2alpha-dependent PAI-1 induction contributes to angiogenesis in hepatocellular carcinoma
Geis, T., Döring, C., Popp, R., Grossmann, N., Fleming, I., Hansmann, M., Dehne, N., & Brüne, B. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.11.018 · Cited by 55
Self-citationThe significant role of telomerase activity in human brain tumors
Nakatani, K., Yoshimi, N., Mori, H., Yoshimura, S.-I., Sakai, H., Shinoda, J., & Sakai, N. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970801)80:3<421::aid-cncr10>3.0.co;2-z · Cited by 50
Nakao, S., Noda, K., Zandi, S., Sun, D., Taher, M., Schering, A., Xie, F., Mashima, Y., & Hafezi‐Moghadam, A. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.01.011 · Cited by 46
HIF-1α is a negative regulator of plasmacytoid DC development in vitro and in vivo
Weigert, A., Weichand, B., Sekar, D., Sha, W., Hahn, C., Mora, J., Ley, S., Essler, S., Dehne, N., & Brüne, B. (2012) · Blood · doi:10.1182/blood-2012-03-417022 · Cited by 36
Self-citationPierre, S. C., Maeurer, C., Coste, O., Becker, W., Schmidtko, A., Holland, S. M., Wittpoth, C., Geißlinger, G., & Scholich, K. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800201-mcp200 · Cited by 29
Self-citationS1P Regulation of Macrophage Functions in the Context of Cancer
Weigert, A., Weichand, B., & Brüne, B. (2011) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152011797655096 · Cited by 28
Self-citation
Cited by
Pyroptosis: Mechanisms and Diseases
Yu, P., Zhang, X., Liu, N., Tang, L., Peng, C., & Chen, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00507-5 · Cited by 2,353
Tumor-associated macrophages: an accomplice in solid tumor progression
Chen, Y., Song, Y., Du, W., Gong, L., Chang, H., & Zou, Z. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0568-z · Cited by 1,096
The role of interleukin-1 in general pathology
Kaneko, N., Kurata, M., Yamamoto, T., Morikawa, S., & Masumoto, J. (2019) · Inflammation and Regeneration · doi:10.1186/s41232-019-0101-5 · Cited by 617
Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy
Gao, J., Liang, Y., & Wang, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.888713 · Cited by 555
Interleukin-1 Beta—A Friend or Foe in Malignancies?
Bent, R., Moll, L., Grabbe, S., & Bros, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082155 · Cited by 444
Metadata
- Authors
- Weichand, B., Popp, R., Dziumbla, S., Mora, J., Strack, E., Elwakeel, E., Frank, A.-C., Scholich, K., Pierre, S., Syed, S. N., Olesch, C., Ringleb, J., Ören, B., Döring, C., Savai, R., Jung, M., von Knethen, A., Levkau, B., Fleming, I., Weigert, A., & Brüne, B.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2017-07-24
- Volume
- 214
- Issue
- 9
- Pages
- 2695-2713
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2737765537
- Cited by
- 267
- References
- 56
- FWCI
- 8.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.